Akebia Therapeutics
AKBA
#9606
Rank
ยฃ81.82 M
Marketcap
ยฃ0.29
Share price
-8.71%
Change (1 day)
-75.75%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: ยฃ81.82 Million

As of November 2026 Akebia Therapeutics has a market cap of ยฃ81.82 Million. This makes Akebia Therapeutics the world's 9606th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ81.82 M-74.99%
2025ยฃ0.32 B-3.52%
2024ยฃ0.33 B84.9%
2023ยฃ0.18 B108.99%
2022ยฃ87.73 M-70.05%
2021ยฃ0.29 B-1.34%
2020ยฃ0.29 B-49.37%
2019ยฃ0.58 B15.16%
2018ยฃ0.50 B-2.09%
2017ยฃ0.52 B60.85%
2016ยฃ0.32 B20.95%
2015ยฃ0.26 B75.53%
2014ยฃ0.15 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Akebia Therapeutics was reported to be:

ยฃ81.82 Million
by Nasdaq info icon info icon
ยฃ81.82 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ497.71 B 608,185.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ217.23 B 265,392.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ180.12 B 220,045.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
ยฃ0.78 B 865.33%๐Ÿ‡บ๐Ÿ‡ธ USA